OakChart

American Well Corp

AMWLHealthcare·Health Information Services·USA·Micro·NYSE·Nov 11 • 8:38 AM ET

12.020.00 (0.00%)
2026-11-11 15:19 CET
Market cap
206.99 USD m
Revenue, TTM
211.23 USD m
Net income, TTM
-57.10 USD m
Free cash flow, TTM
-19.32 USD m
EPS diluted, TTM
-3.43
P/E
-
Compare

Price

AMWL against its 20, 50 and 200-day averages
2050200beat
7.5010.0012.5015.00233K465KMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AMWLclose 12.0220-day 12.9250-day 12.98200-day 9.2312.02

20.7% under 15.16 on 29 Oct 2026. Last 15 sessions, 34.6% high to low

Profile

AMWL
52-week range, 73% of the way up
3.7115.16

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Employees562
IPOSep 17, 2020
Beta1.69
ATR, 14d0.91
Rel volume0.00
Short float1.79%
Insider own18.96%
Inst own42.41%

Snapshot

6 groups

Valuation

Index-
Market Cap206.99M
Enterprise Value40.91M
Income-57.10M
Sales211.23M
Book/sh12.35
Cash/sh10.54
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees562
IPOSep 17, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S0.98
P/B0.97
P/C1.14
P/FCF-
EV/EBITDA-
EV/Sales0.19
Quick Ratio2.97
Current Ratio2.98
Debt/Eq0.01
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-3.43
EPS next Y-1.84
EPS next Q-0.46
EPS this Y61.09%
EPS next Y20.49%
EPS next 5Y42.72%
EPS past 3/5Y32.88% 20.73%
Sales past 3/5Y-3.47% 0.33%
EPS Y/Y TTM52.30%
Sales Y/Y TTM-20.30%
EPS Q/Q66.65%
Sales Q/Q-12.96%
EarningsNov 03 AMC
EPS/Sales Surpr.13.55% 3.61%

Ownership

Insider Own18.96%
Insider Trans-2.34%
Inst Own42.41%
Inst Trans6.86%
ROA-17.08%
ROE-24.47%
ROIC-26.97%
Gross Margin38.67%
Oper. Margin-27.20%
Profit Margin-27.03%
SMA20-6.97%
SMA50-7.38%
SMA20030.26%
Trades-

Technical

Shs Outstand15.49M
Shs Float13.96M
Short Float1.79%
Short Ratio2.28
Short Interest0.25M
52W High15.16 -20.71%
52W Low3.71 223.99%
Volatility10.48% 7.92%
ATR (14)0.91
RSI (14)43.34
Beta1.69
Rel Volume0.00
Avg Volume109.98K
Volume1

Performance

Perf Week-2.67%
Perf Month-1.23%
Perf Quarter-7.11%
Perf Half Y55.50%
Perf YTD144.81%
Perf Year208.21%
Perf 3Y-46.34%
Perf 5Y-92.68%
Perf 10Y-
Recom2.75
Target Price13.33
Prev Close12.02
Price12.02
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jan 13, 2025UpgradeWWells FargoEqual Weight → Overweight$15+24.8%
Aug 03, 2023DowngradeMMorgan StanleyOverweight → Equal-Weight$5 → $2.50-79.2%
Mar 23, 2023DowngradeTTD CowenOutperform → Market Perform$5 → $2.50-79.2%
Feb 27, 2023DowngradePPiper SandlerOverweight → Neutral$5 → $3.50-70.9%
Jan 04, 2023UpgradeBBofA SecuritiesNeutral → Buy$4.20-65.1%
Sep 07, 2022InitiatedTTruistHold$5-58.4%
Apr 14, 2022InitiatedGGuggenheimBuy$6-50.1%
Apr 01, 2022ResumedCCredit SuisseNeutral$5-58.4%
Feb 11, 2022InitiatedGGoldmanNeutral$6-50.1%
Dec 02, 2021InitiatedJJefferiesHold$6-50.1%

Peers

Mkt cap
TickerCompanyMkt cap
TDOCTeladoc Health Inc1.64B
LFMDLifeMD Inc84.35M
OMDAOmada Health Inc946.70M
DRIODarioHealth Corp23.42M
PHRPhreesia Inc782.71M
HNGEHinge Health Inc9.66B
DOCSDoximity Inc5.80B
HIMSHims & Hers Health Inc4.54B
LFSTLifeStance Health Group Inc5.52B

Insider trading

latest 14 of 48
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Gotlib PhyllisPresident, InternationalOct 01 '26Sale13.006,67786,801142,504Oct 05 05:32 PM
HIRSCHHORN MARKChief Financial OfficerOct 01 '26Sale13.004,28255,666223,906Oct 05 05:28 PM
Zamansky DmitryChief Product & Tech. OfficerOct 01 '26Sale13.008,442109,746224,178Oct 05 05:25 PM
McNeice Paul FrancisChief Accounting OfficerOct 01 '26Sale13.006538,4899,086Oct 05 05:23 PM
Mark HirschhornOfficerOct 01 '26Proposed Sale13.004,28255,668Oct 01 05:21 PM
Dmitry ZamanskyOfficerOct 01 '26Proposed Sale13.008,442109,750Oct 01 05:04 PM
Phyllis GotlibOfficerOct 01 '26Proposed Sale13.006,67786,804Oct 01 05:00 PM
HIRSCHHORN MARKChief Financial OfficerSep 01 '26Sale11.8010,751126,862228,188Sep 03 05:11 PM
Gotlib PhyllisPresident, InternationalSep 01 '26Sale11.803,57342,161149,181Sep 03 05:09 PM
McNeice Paul FrancisChief Accounting OfficerSep 01 '26Sale11.801121,3229,739Sep 03 05:06 PM
Mark HirschhornOfficerSep 01 '26Proposed Sale11.8010,751126,897Sep 01 05:18 PM
Phyllis GotlibOfficerSep 01 '26Proposed Sale11.803,57342,173Sep 01 05:15 PM
McNeice Paul FrancisChief Accounting OfficerJul 01 '26Sale9.336536,0929,851Jul 01 05:23 PM
HIRSCHHORN MARKChief Financial OfficerJul 01 '26Sale9.334,29940,110238,939Jul 01 05:20 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
IWCiShares Micro-Cap ETFAUM: 1.22B
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B
DFMCU.S. Micro Cap Portfolio ETF Class Shares-
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
DXUVUS Vector Equity Portfolio ETF Class Shares-
PRFZInvesco RAFI US 1500 Small-Mid ETFAUM: 2.66B
DCORUS Core Equity 1 Portfolio ETF Class Shares-

News

latest 14 of 206
  • Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members (GlobeNewswire)
  • Amwell makes grant to new employees under inducement plan (GlobeNewswire)
  • Amwell Misses By A Penny But Raises Outlook And Targets First Positive EBITDA Quarter As 2027 Growth Timeline Slips (Earnings Whispers)
  • Amwell Announces Results for the Third Quarter 2026 (GlobeNewswire)
  • Amwell's Profit Turn Faces A Seasonal Test As DHA Contract And Q4 Cash Goals Loom (Earnings Whispers)
  • Loading…
  • Amwell to report third quarter 2026 operating results (GlobeNewswire)
  • Discovery Health expanded access to mental healthcare for 22,000 members in one year, with better outcomes and lower hospital costs (GlobeNewswire)
  • Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year? (Trefis)
  • Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure (GlobeNewswire)
  • Amwell receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation (GlobeNewswire)
  • Amwell to participate in upcoming investor conferences (GlobeNewswire) +6.30%
  • Amwell makes grant to new employees under inducement plan (GlobeNewswire)
  • American Well Corp (AMWL) (Q2 2026) Earnings Call Highlights: Narrows Losses, Secures Key DHA ... (GuruFocus.com) +24.95%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-03-0.670-0.775-0.67048.9947.288
2026Q22026-08-04-0.590-0.860-0.59252.0549.887
2026Q12026-05-05-0.660-1.174-0.65654.8851.547
2025Q42026-02-12-1.520-1.801-1.52055.3152.648
2025Q32025-11-04-2.000-1.814-1.99756.2955.069
2025Q22025-08-05-1.240-1.773-1.23970.9063.479
2025Q12025-05-01-1.190-2.766-1.19366.8360.1610
2024Q42025-02-12-2.770-2.927-2.77071.0166.689
2024Q32024-10-30-2.870-3.407-2.87261.0562.8710
2024Q22024-07-31-3.360-3.986-3.35662.7961.5712
2024Q12024-05-01-5.000-3.996-4.94259.5260.5312
2023Q42024-03-19-3.400-3.958-3.37470.6870.1611
2023Q32023-11-01-9.600-4.186-9.54361.9263.0711
2023Q22023-08-02-6.600-4.478-6.53462.4565.8712
2023Q12023-05-03-28.400-4.228-28.41064.0064.7112
2022Q42023-02-22-4.486-5.104-4.41479.2078.0811

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-45.400-28.270-19.052245.27238.69
2021FY-13.800-15.794-13.881252.79248.95
2022FY-19.800-20.470-19.721277.2276.06
2023FY-47.600--47.504259.05-
2024FY-13.880-13.229-13.877254.36249.88
2025FY-5.960-6.165-5.960249.33246.57
2026FY--2.319--205.24
2027FY--1.844--209.59
2028FY--1.120--223.21
2029FY--0.605--236.24
2030FY--0.060--254.8

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0462149.3349.0749.85
2026Q4S2026-11-0360049.0448.1049.91
2026Q4S2026-10-2560049.0448.1049.91
2026Q4S2026-10-1960149.0448.1049.91
2026Q4S2026-08-1260449.0448.1049.91
2026Q4S2026-08-1160449.0448.1049.91
2026Q4S2026-08-0561349.8948.1053.78
2026Q4S2026-08-0461050.4749.4953.78
2026Q4S2026-07-2061050.4749.4953.80
2026Q4S2026-06-0462250.4749.4953.80
2026Q4S2026-05-0661249.9649.4950.75
2026Q4S2026-04-2960049.6946.1151.29
2026Q4S2026-02-1860549.6946.1151.29
2026Q4S2026-02-1360549.6946.1151.29

Estimate history

EPS, annual-4.583-7.585-19.052-13.881-19.721-47.504-13.877-5.964-3.434
Period20182019202020212022202320242025TTM
EPS, quarterly-2.872-2.77-1.193-1.239-1.997-1.52-0.656-0.592-0.666
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual113.955148.857245.265252.789277.19259.047254.364249.325211.23
Period20182019202020212022202320242025TTM
Sales, quarterly61.04671.00666.83370.89856.28655.30854.88352.04848.991
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual11.49511.49511.7813.09413.85714.42415.5716.4317.137
Period20182019202020212022202320242025MRQ
Shares, quarterly15.28715.5715.78516.08916.3216.4316.65916.92517.137
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue211.23249.32254.36259.05277.19252.79245.26148.86113.95
Cost of Goods Sold Incl. D&A129.55149.18188.39195.78186.57164.56166.9487.7463.94
Gross Profit81.68100.1465.9863.2790.6188.2378.3261.1250.01
Selling, General and Administrative Excl. Other139.14194.22262.62314.52348.74268.89299.28154.33103.93
Research and Development45.6768.0886.06105.83138.49106.5984.4153.9436.27
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-57.47-94.07-196.64-251.25-258.12-180.66-220.96-93.21-53.92
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense6.3211.2020.89440.8917.73-1.526.481.491.19
Net Income Before Taxes-56.05-92.84-206.78-672.72-269.73-179.03-225.80-89.17-52.31
Income Taxes-0.190.432.753.860.06-5.380.64-0.800.00
Consolidated Net Income-56.05-94.97-212.64-679.17-272.07-176.78-228.63-88.37-52.31
Net Income From Continuing Operations-57.10-95.70-208.14-675.16-270.43-176.33-224.43-87.19-52.67
Net Income-57.10-95.70-208.14-675.16-270.43-176.33-224.43-87.19-52.67
EPS (Recurring)-3.09-5.47-12.90-25.79-18.82-13.96-18.67-7.49-4.51
EPS (Basic, Before Extraordinaries)-3.43-5.96-13.88-47.50-19.72-13.88-19.05-7.59-4.58
EPS (Diluted)-3.43-5.96-13.88-47.50-19.72-13.88-19.05-7.59-4.58
EBITDA-28.64-59.09-163.21-219.33-231.35-163.84-209.95-84.74-48.02
Non-Operating Income (Expense)7.7412.4410.7619.426.120.121.635.542.79
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense8.8617.3237.5356.9154.6231.9854.608.867.67
Price To Sales Ratio1.100.320.431.642.806.0724.33--
Gross Margin38.6740.1725.9424.4232.6934.9031.9341.0643.89
Operating Margin-27.20-37.73-77.31-96.99-93.12-71.47-90.09-62.62-47.32
Net Margin-27.03-38.38-81.83-260.63-97.56-69.76-91.51-58.57-46.22
Shares Outstanding17.1416.4315.5714.4213.8613.0911.7811.4911.49
Market Capitalization206.99206.99111.07427.61778.961,581.705,967.856,319.67-

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue48.9952.0554.8855.3156.2970.9066.8371.01
Cost of Goods Sold Incl. D&A28.2131.5034.4835.3736.2239.3739.3744.82
Gross Profit20.7920.5520.4019.9420.0631.5327.4626.18
Selling, General and Administrative Excl. Other31.9630.7533.3543.0946.2048.7854.4164.87
Research and Development9.3310.2912.3813.6718.5818.2422.1018.78
Other Operating Expense0.000.000.000.000.000.590.000.00
Operating Income-11.17-10.20-12.95-23.15-26.14-17.84-26.95-38.69
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.48-0.644.482.003.192.543.464.07
Net Income Before Taxes-10.19-10.17-10.08-25.60-30.69-19.53-17.01-42.33
Income Taxes0.77-0.550.22-0.631.22-0.720.571.53
Consolidated Net Income-10.96-9.62-10.30-25.17-31.91-19.53-18.36-44.57
Net Income From Continuing Operations-11.36-9.93-10.89-24.92-32.38-19.70-18.70-42.65
Net Income-11.36-9.93-10.89-24.92-32.38-19.70-18.70-42.65
EPS (Recurring)-0.65-0.62-0.47-1.43-1.86-1.13-1.04-2.58
EPS (Basic, Before Extraordinaries)-0.67-0.59-0.66-1.52-2.00-1.24-1.19-2.77
EPS (Diluted)-0.67-0.59-0.66-1.52-2.00-1.24-1.19-2.77
EBITDA-5.87-3.11-5.29-14.38-16.42-9.36-18.93-30.29
Non-Operating Income (Expense)1.47-0.627.34-0.45-1.360.8413.400.42
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.841.601.823.603.184.476.078.56
Price To Sales Ratio1.100.700.370.320.380.520.470.44
Gross Margin42.4339.4837.1736.0635.6544.4741.0936.88
Operating Margin-22.80-19.60-23.59-41.85-46.44-25.16-40.32-54.48
Net Margin-23.19-19.07-19.83-45.06-57.52-27.78-27.99-60.07
Shares Outstanding17.1416.9316.6616.4316.3216.0915.7815.57
Market Capitalization206.99152.3887.0680.3899.34140.55123.01111.07

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments182.33228.32372.04538.55746.421,042.67177.63261.20
Short Term Receivables49.6971.8954.1558.3751.3845.3032.7330.78
Inventories1.192.866.658.747.539.133.102.51
Other Current Assets10.8111.4214.4819.5720.2814.058.223.31
Total Current Assets244.02314.48447.32625.22825.601,111.15221.68297.81
Net Property, Plant & Equipment4.167.5811.0314.5218.6610.4514.613.08
Total Investments and Advances0.802.291.980.800.960.751.141.09
Intangible Assets66.07101.54120.25570.26595.17249.41257.41182.66
Other Assets8.7410.089.146.765.454.895.044.68
Total Assets323.79435.97589.711,217.561,445.841,376.65499.88489.31
Short Term Debt Incl. Current Port. of LT Debt3.633.693.583.061.926.366.230.00
Accounts Payable1.655.014.867.2412.165.806.504.23
Other Current Liabilities67.93102.5685.35103.76127.55108.8393.8483.61
Total Current Liabilities73.21111.2693.80114.06141.63120.98106.5887.83
Long Term Debt0.894.518.2111.7914.691.307.160.00
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Other Liabilities1.893.957.527.8628.648.1711.2130.18
Total Liabilities76.00119.72109.52133.71184.96130.45124.95118.01
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00655.80575.71
Common Equity235.58304.77464.221,063.881,239.261,224.13-307.12-231.84
Total Shareholders Equity235.58304.77464.221,063.881,239.261,224.13348.68343.87
Accumulated Minority Interest12.2111.4715.9719.9721.6222.0726.2627.43
Total Equity247.79316.24480.191,083.851,260.881,246.20374.94371.30
Total Liabilities & Stockholders Equity323.79435.97589.711,217.561,445.841,376.65499.88489.31
Book Value Per Share14.3419.5732.1876.7894.65103.91-26.72-20.17
Tangible Book Value Per Share10.3213.0523.8535.6249.1982.74-49.11-36.06
Full-Time Employees5628771,1041,0351,035812686-
Price to Book Ratio0.970.330.850.721.284.884.96-
Return on Assets-25.19-40.59-74.72-20.31-12.49-23.92-17.63-
Return on Equity-35.42-54.13-88.37-23.48-14.32-28.54-25.18-
Return on Invested Capital-40.47-67.30-142.91-25.14-14.06-18.31-24.50-15.32
Quick Ratio3.322.804.705.415.789.112.053.36
Current Ratio3.332.834.775.485.839.182.083.39

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-56.05-94.97-212.64-679.17-272.07-176.78-228.63-88.37-52.31
Depreciation28.8034.9833.4331.9426.7916.8311.018.475.90
Other Funds (Non Cash)16.8021.9462.09514.6383.5852.38123.6013.919.17
Funds from Operations-11.53-39.16-117.36-132.84-164.23-113.82-94.02-67.37-37.23
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-7.76-26.80-9.98-15.51-28.10-27.71-18.45-14.52-36.77
Cash from Operating Activities-19.29-65.95-127.34-148.34-192.32-141.54-112.46-81.89-74.01
Capital Expenditures-8.63-0.02-15.22-15.25-10.45-0.56-3.32-1.34-1.91
Net Assets From Acquisitions0.000.000.000.000.00-156.530.00-45.75-64.38
Sale of Fixed Assets and Businesses4.9518.320.000.000.000.000.000.000.00
Purchase or Sale of Investments-0.20-1.20-3.43-3.92-1.1897.45-63.44167.09-179.64
Purchase of Investments-0.20-1.20-3.43-393.91-501.18-2.55-162.55-78.95-355.24
Sale Or Maturity of Investments0.000.000.00389.99500.00100.0099.11246.03175.60
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-3.8817.10-18.65-19.17-11.63-59.63-66.76120.00-245.93
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.540.841.382.157.884.16983.1246.64278.18
Repurchase of Common Pref Stock-0.00-0.00-0.00-0.59-0.36-15.04-37.57-0.16-2.90
Sale of Common Pref Stock0.540.841.382.738.2419.191,020.6846.80281.08
Proceedsfrom Stock Options0.000.000.000.000.00-1.611,014.7545.76280.44
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.00-11.491.600.000.000.00
Other Financing Activities Uses0.000.000.000.00-11.790.000.000.000.00
Cash from Financing Activities0.540.841.382.15-3.615.75983.1246.64278.18
Exchange Rate Effect2.522.020.89-1.14-0.30-0.08---
Net Change in Cash-20.10-45.99-143.72-166.51-207.87-195.50803.8984.75-41.76
Free Cash Flow-19.32-65.97-127.46-148.53-192.62-142.10-115.78-83.23-75.92
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit--1.11-0.24-0.24-2.52-6.250.00-1.390.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments181.58196.74180.00182.33200.89219.07
Short Term Receivables54.4952.6157.0949.6955.5853.56
Inventories0.890.961.151.191.822.18
Other Current Assets9.6811.7218.1310.8110.2512.25
Total Current Assets246.64262.03256.37244.02268.54287.06
Net Property, Plant & Equipment0.150.170.184.165.015.88
Total Investments and Advances0.000.000.000.801.790.80
Intangible Assets54.7256.9561.0966.0774.5684.03
Other Assets7.718.048.338.749.5210.89
Total Assets309.22327.18325.97323.79359.43388.66
Short Term Debt Incl. Current Port. of LT Debt2.012.983.963.633.683.70
Accounts Payable3.841.701.391.655.963.73
Other Current Liabilities76.8686.5978.4267.9376.8480.49
Total Current Liabilities82.7191.2683.7773.2186.4987.92
Long Term Debt0.000.000.000.891.782.69
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities1.341.612.071.893.793.48
Total Liabilities84.0592.8785.8476.0092.0694.08
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity211.67221.22227.33235.58254.91282.59
Total Shareholders Equity211.67221.22227.33235.58254.91282.59
Accumulated Minority Interest13.4913.0912.7912.2112.4511.98
Total Equity225.17234.31240.12247.79267.36294.57
Total Liabilities & Stockholders Equity309.22327.18325.97323.79359.43388.66
Book Value Per Share12.3513.0713.6514.3415.6217.56
Tangible Book Value Per Share9.169.719.9810.3211.0512.34
Full-Time Employees---562--
Price to Book Ratio0.970.670.370.310.350.48
Return on Assets-17.08-21.82-23.58-25.19-26.93-27.78
Return on Equity-24.47-31.01-33.72-35.42-38.35-38.52
Return on Invested Capital-5.37-4.49-4.79-10.54-12.61-6.90
Quick Ratio2.972.863.053.323.083.24
Current Ratio2.982.873.063.333.103.27

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-10.96-9.62-10.30-25.17-31.91-19.53
Depreciation5.307.087.668.779.728.48
Other Funds (Non Cash)3.063.001.519.236.648.09
Funds from Operations-2.590.46-1.14-8.25-15.57-2.97
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-9.0710.260.16-9.11-3.20-1.76
Cash from Operating Activities-11.6710.72-0.98-17.36-18.77-4.72
Capital Expenditures-2.97-2.86-2.79-0.010.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.007.030.00-2.080.000.00
Purchase or Sale of Investments0.000.000.00-0.200.000.00
Purchase of Investments0.000.000.00-0.200.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-2.974.17-2.79-2.290.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.240.000.30-0.000.30-0.00
Repurchase of Common Pref Stock-0.000.000.00-0.00-0.00-0.00
Sale of Common Pref Stock0.240.000.300.000.300.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.240.000.30-0.000.30-0.00
Exchange Rate Effect-0.761.850.341.080.281.39
Net Change in Cash-15.1616.74-3.12-18.56-18.18-3.34
Free Cash Flow-11.6810.71-0.99-17.37-18.77-4.72

Revenue breakdown

Others2024: 22.37M 2025: 22.63M
Platform Subscription2024: 115.54M 2025: 132.41M
Visits2024: 116.46M 2025: 94.29M
United States2024: 254.36M 2025: 249.33M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.79%0.3M14.0M111.80K
2026-10-151.50%0.2M13.8M112.84K
2026-09-301.25%0.2M13.8M122.18K
2026-09-151.17%0.2M13.8M120.07K
2026-08-310.96%0.1M13.8M121.24K
2026-08-141.17%0.2M13.7M122.86K
2026-07-311.19%0.2M13.7M111.21K
2026-07-151.41%0.2M13.3M93.81K
2026-06-301.32%0.2M13.3M79.83K
2026-06-151.43%0.2M13.0M73.04K
2026-05-291.52%0.2M13.1M66.90K
2026-05-151.80%0.2M13.3M66.24K
2026-04-301.93%0.3M13.4M87.28K
2026-04-152.34%0.3M13.0M88.47K
2026-03-312.38%0.3M13.0M93.63K
2026-03-131.98%0.3M13.0M110.82K
2026-02-272.35%0.3M13.0M118.37K
2026-02-132.65%0.3M13.0M124.73K
2026-01-301.28%0.2M12.8M113.60K
2026-01-151.12%0.1M12.8M119.58K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.000.00-0.000.00---
call5.000.000.000.00-0.000.00---
call7.500.000.000.00-0.000.00---
call10.000.000.003.65-70.000.00---
call12.500.000.001.07-12.000.00---
call15.000.000.001.29-64.000.00---
call17.500.000.000.33-6.000.00---
call20.000.000.000.00-0.000.00---
call22.500.000.000.00-0.000.00---
call25.000.000.000.05-1.000.00---
put2.500.000.000.00-0.000.00---
put5.000.000.000.00-0.000.00---
put7.500.000.000.00-0.000.00---
put10.000.000.000.30-2.000.00---
put12.500.000.000.74-38.000.00---
put15.000.000.002.80-1.000.00---
put17.500.000.000.00-0.000.00---
put20.000.000.000.00-0.000.00---
put22.500.000.000.00-0.000.00---
put25.000.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-218-KCurrent report2026-07-14SEC
2026-07-148-KCurrent report2026-07-08SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-01144Filing for proposed sale of securities under Rule 144.SEC
2026-07-01144Filing for proposed sale of securities under Rule 144.SEC
2026-07-01144Filing for proposed sale of securities under Rule 144.SEC
2026-06-228-KCurrent report2026-06-16SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-06-16SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-1000260.70K4
2026-0900170.34K3
2026-080000
2026-0700187.43K4
2026-0600226.15K4
2026-054.94K100
2026-040051.22K3
2026-030089.45K4
2026-020000
2026-010050.12K3
2025-120017.84K3
2025-110000

Institutional holders

Manager% owned
Senvest Management, LLC7.95%
MORGAN STANLEY7.65%
Cable Car Capital, LP6.00%
VANGUARD CAPITAL MANAGEMENT LLC3.66%
ACADIAN ASSET MANAGEMENT LLC3.13%
BlackRock, Inc.2.56%
RENAISSANCE TECHNOLOGIES LLC1.58%
Russell Investments Group, Ltd.1.03%
GEODE CAPITAL MANAGEMENT, LLC0.92%
TWO SIGMA INVESTMENTS, LP0.87%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.56%
VANGUARD EXTENDED MARKET INDEX FUND0.96%
U.S. Small Cap Equity Fund0.42%
Fidelity Extended Market Index Fund0.30%
Dimensional U.S. Small Cap ETF0.29%
iShares Micro-Cap ETF0.29%
Ultra-Small Company Fund0.26%
Dunham Small Cap Value Fund0.18%
Fidelity Total Market Index Fund0.17%
SIIT SMALL CAP II FUND0.17%

OakChart. AMWL. Cached 15 minutes.